Two Sigma Securities LLC bought a new stake in Danaher Corporation (NYSE:DHR – Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 4,083 shares of the conglomerate’s stock, valued at approximately $778,000.
Several other institutional investors and hedge funds have also recently bought and sold shares of DHR. Main Street Group LTD purchased a new position in Danaher during the 1st quarter worth $25,000. N.E.W. Advisory Services LLC purchased a new stake in shares of Danaher in the second quarter valued at about $25,000. JPL Wealth Management LLC acquired a new stake in shares of Danaher during the third quarter worth about $25,000. WFA of San Diego LLC acquired a new stake in shares of Danaher during the second quarter worth about $26,000. Finally, Hilton Head Capital Partners LLC acquired a new position in Danaher in the 4th quarter valued at about $27,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Danaher Trading Down 3.1%
Shares of DHR opened at $206.89 on Wednesday. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The stock has a market cap of $145.44 billion, a price-to-earnings ratio of 36.75, a price-to-earnings-growth ratio of 2.66 and a beta of 0.78. The firm has a 50 day simple moving average of $200.73 and a 200-day simple moving average of $192.22. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25.
Analyst Upgrades and Downgrades
A number of research firms have weighed in on DHR. Evercore reaffirmed an “outperform” rating and set a $230.00 price objective on shares of Danaher in a research report on Monday, July 6th. Piper Sandler initiated coverage on shares of Danaher in a research report on Thursday, June 11th. They issued a “neutral” rating and a $200.00 price objective on the stock. Wolfe Research cut shares of Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. Guggenheim cut their price target on shares of Danaher from $235.00 to $200.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. Finally, TD Cowen reduced their price objective on shares of Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Danaher has a consensus rating of “Moderate Buy” and a consensus price target of $228.91.
Get Our Latest Stock Analysis on DHR
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Further Reading
- Five stocks we like better than Danaher
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
